You may have autoimmune gastroparesis even if you have no other symptoms of autoimmune disease, or if your other symptoms are unrelated to your stomach
Lotte Bjerre Knudsen (24:34): So I'm not sure we can say that it comes before the weight loss because the energy intake reduction happens instantly
While GLP-1 medications can help manage these conditions, they are contraindicated during pregnancy, and women are typically advised to stop the medication two months before attempting to conceive
The rationale for re-titration relates to gastrointestinal tolerability
doctors are prescribing them to children at unprecedented rates
, June 23, 2023 Chugai, Shizuoka, JP / Eli Lilly, Indianapolis, IN Orforglipron is the first oral, non-peptide GLP-1 receptor partial agonist approved by the FDA for obesity, with a regulatory filing in type 2 diabetes expected in 2026